US biologics contract manufacturer Omnia Biologics has announced a
master services agreement to provide drug development company
Intradigm with process development and current good manufacturing
practice (cGMP) services for cancer...
Water purification company Meco, which was nearly destroyed in
Hurricane Katrina's aftermath, showed at Interphex it can bounce
back and showcased its latest products to
In-PharmaTechnologist.com.
After branching out of the US with the opening of new facilities in
Singapore and India and a recent Eastern European acquisition,
US-based Albany Molecular Research (AMR) used Interphex 2006 to
highlight its new range of global services.
US-based MicroTest Laboratories (MTL) has won two new manufacturing
contracts after a facility expansion completed last year allowed
the company to expand into making commercial-scale products.
Court Square, a provider of IT service offerings for both large and
small biopharma firms, has seized upon what it saw as a gap in the
market to open up a dedicated life sciences division for small and
medium-sized companies (SMEs).
Researchers have been working on a better laboratory method of
detecting ovarian cancer, which is set to improve on routine
screening that is currently available to women by improving
sensitivity to detect the cancer in its earliest...
The damages caused by a patent dispute can sometimes wipe out the
assets side of a company's balance sheet - a potential death
sentence for small or medium companies - many of which aren't doing
enough to protect themselves,...
Italian packaging and processing machinery company IMA Group has
posted a net profit of €13m for 2005, down 24 per cent from 2004,
since a rise in revenues was offset by one-off charges, operating
costs and a reduction in prices as...
US filtration giant Millipore is pumping more resources into its
personnel and facilities in Asia, as outsourcing trends and new
laboratory investments in emerging markets such as China and India
are upping demand for its bioscience...
Nastech Pharmaceuticals presents data demonstrating the
effectiveness of its small interfering RNA (siRNA) therapeutics to
target and inhibit influenza viral production, which is certain to
have useful applications against current...
Scientists in the US have found out how the enzyme helps initiate
the process that leads to colorectal cancer. Their discovery of a
new molecular mechanism by which an enzyme promotes cancer spread
may provide a new target at which...
Multisorb used the recent Interphex trade show to introduce its new
range of consulting services to accompany its well-known range of
sorbent products and save customers both time and money in drug
packaging.
Manufacturers of single-use process components and systems within
the biopharma industry in the US have launched a new alliance at
Interphex to educate, standardise, and develop guidelines that
safeguard the quality of drugs produced...
A new report out today has revealed that the uptake of assays for
in-vitro diagnostics is being hindered due to a lack of knowledge
of this technology, in which its high sensitivity, specificity and
fast turn-around times has proved...
A leading scientist believes that cosmetic considerations and a
lack of patent opportunities is stopping the pharmaceutical
industry from investing in the development of a new therapy proven
to be effective in the treatment of MRSA.
Scientists have made a breakthrough in their research that may
change the way inflammatory conditions are treated by focusing on
certain nerve cell receptors in the brain that control inflammation
in the body.
Nilfisk used Interphex, New York, to showcase its new vacuum
designed to collect sub-micron particles and bring the cleanliness
and hygiene standards required in cleanrooms into a compact
machine.
Spending up to $400m (€330m), Indian drugmaker Ranbaxy has ended
the week with three acquisitions of European generic companies
under its belt, hoping a strong foothold in Europe will help it
offset its declining fortunes in the US.
Illumina has introduced two new genotyping BeadChips that offers
the highest data quality of any genotyping array currently
available, with call rates that routinely exceed 99 per cent,
reproducibility and accuracy approaching 100...
Level and flow measurement product providers, Krohne, were out in
force at Interphex 2006, showcasing a raft of products for the
manufacturing industry. Its presence within the pharma and chemical
industry has been boosted recently...
Modular optimal subsystems developer Polychromix has released what
it claims is the first data analysing all-in-one spectroscopic
unit, allowing anyone to perform chemical analysis in the field at
an unprecedented low cost.
As pharma companies tighten their belts, they are expecting more
and more cost savings from their outsourcing providers. IT services
company HCL Technologies spoke to Outsourcing-Pharma.com at
Interphex in New York to explain how...
No company likes to hire and fire unnecessarily. When used
correctly, outsourcing can be the key to maintaining the proper
balance of fixed and variable staffing and allow the right staffing
resources to be rapidly shifted to the...
Agilent has upgraded its GeneSpring GX 7.3 gene expression
informatics software, giving it new features designed to allow
researchers to understand faster what their results really mean.
ExonHit and bioMirieux have announced that scientific data
generated in the detection of breast cancer could well lead to the
development of novel diagnostic tests that will enable the early
detection of breast cancer from blood.
Despite the technological breakthroughs that have enhanced the
R&D capabilities of pharmaceutical companies, drug research and
development is facing a major problem as R&D productivity in
the last decade is at a historical...
Upstate and Cisbio have announced the launch of an assay for
Serine/Threonine kinase screening that offers simplified kinase
assay development, which allows for profiling and high-throughput
screening (HTS) on a large range of Ser/Thr...
Nypro, a large US-based provider of precision plastics injection
moulding, has been contracted to manufacture Ventaira's new
pulmonary drug delivery device.
Scientists have discovered the existence of a HIV accessory protein
that disables host immunity via receptor-protein intermediary in a
discovery that points to possible novel ways to fight AIDS, immune
disorders and sepsis.
Eriez used the recent Interphex show to launch its new
magnetically-driven vibratory feeder for large quantities of bulk
drug materials, designed to save manufacturers both time and money.
New legislation on the good manufacturing practice (GMP) of
pharmaceutical excipients in Europe, which could complicate the
quality control of imports of excipients to the EU and make it
unattractive for some vendors to remain in...
Elsevier have launched a drug tracking and analysis tool that is
set to greatly benefit laboratory researchers working in the
pharmaceutical and biotech professionals by bringing together drug
characteristics and status within a database.
Dutch biotechnology firm Crucell has announced it will sell vaccine
manufacturer Rhein Biotech to US company Dynavax for around $12m
(€10m) as it chooses to focus on specialised vaccines such as those
for Ebola and malaria.
Inspection technology specialist PTI has launched a new
non-invasive inspection system at INTERPHEX for multi-cavity
blister packaging made with any material, flat or glossy finish,
printed or nonprinted surface, allowing fast changeover...
The Optima Group's presence at this year's Interphex show in New
York was significant as it gave In-PharmaTechnologist.com the first
look at the Group's recently implemented shift in focus, resulting
in a product range...
inVentiv Health (Formerly Ventiv Health) saw its fourth quarter
profits dive in 2005 by 37 per cent after being hit by higher
interest expenses and an income tax provision, however, the company
managed to increase its sales for the...
Outsourcing-Pharma focus on: cutting the cost of clinical trials
As pharma companies flock towards Eastern Europe and India in a bid
to cut direct clinical trial costs, does outsourcing actually
translate into real world cost-savings?
Affymetrix introduces its new ChIP-On-Chip array product line that
its designers hope will provide drug researchers with new
whole-genome tools to assist scientists discover DNA-Protein
interactions.
New diabetes trials scheduled to start this spring have been
heralded as groundbreaking as researchers aim to reverse juvenile
diabetes of which numbers have been steadily on the rise in
developed nations.
Scientists have made available a powerful new tool for studying
brain development, which will help scientists discover the genetic
origins of brain cancers, which could speed development of novel
drugs to treat them.
Outsourcing company, Covalent Group, has announced the signing of a
$2.1M (€1.7M) contract to provide a range of services to support
the research and development of new therapies to treat
hyponatremia.
Researchers have discovered a series of enzyme inhibitors that
appear to block the replication of the SARS virus - a finding that
could help speed up the research and development of drugs used to
treat the killer virus.
Ranbaxy has announced the purchase of Senetek's Autoinjector rights
and assets for its proprietary disposable autoinjector for
self-administration of parenteral drugs, adding to Ranbaxy's
growing presence in the growing...
Rapid growth in the biopharmaceutical sector in China, India and
Southeast Asia has prompted US filtration specialist Pall to devote
more resources and industry experts to these regions, as the 14 per
cent growth seen in its BioPharm...
Systech and Domino Printing Sciences has announced an agreement
that will combine Systech's TIPS Serialised Product Tracking
methods with Domino's marking and coding technology as a solution
to combat counterfeit product...
Looking to establish itself in Eastern Europe, French drug maker
Sanofi-Aventis has bought a 24.9 per cent stake in Czech generic
drug firm Zentiva for $514.7m (€430m).
A simple laboratory method to treat Parkinson's disease, which
involves electric currents, has been developed by researchers, who
believe the use of this method will reduce or eliminate the need to
treat this disorder with drug...
Despite hurdles such as manufacturing overcapacity, limited drug
approvals and intense competition from Asian companies, a new
report from market research analysts Frost & Sullivan predicts
revenues in the North American fine...
Organon, Akzo Nobel's healthcare division, has conceded it will
have to close its Diosynth manufacturing plant in Scotland by the
end of the year since it cannot divest it, as the unit's lack of
competitiveness in the production...
LGC Promochem has launched its 2006 edition of its free
pharmaceutical reference substances and impurities catalogue,
providing researchers and analysts in the pharmaceutical R&D
and manufacturing generic industry with a central...
